GlassScriptPhysician profile
Sanjeev Nair
NPI 1962656801
$8,388.15
in general payments reported to CMS, 2019-2025
40 companies · $2,541 in 2025
The $2,541 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $1,041 · 2021: $219 · 2022: $1,746 · 2023: $923 · 2024: $931 · 2025: $2,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,141 · Travel and Lodging: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,140.54 |
| Travel and Lodging | $1,255.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,275.57 | 2019-2025 | Ekosonic, Eluvia, Latitude Communicator Power Supply |
| Abbott Laboratories | $704.07 | 2021-2025 | Jot Dx, Ensite, Amplatzer |
| Medtronic Vascular, INC. | $575.29 | 2020 | |
| Abiomed | $565.84 | 2019-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $489.90 | 2019-2025 | |
| Shockwave Medical, INC | $439.09 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $284.22 | 2019-2024 | Penumbra System |
| Amgen INC. | $178.51 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $157.81 | 2023 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $155.29 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $155.20 | 2019-2022 | |
| Inspire Medical Systems, INC. | $129.85 | 2024 | Inspire |
| Lantheus Medical Imaging, INC. | $108.65 | 2020-2024 | |
| Ceribell, INC. | $107.94 | 2024 | Pocket Eeg Device |
| Astrazeneca Pharmaceuticals LP | $107.54 | 2019-2024 | Farxiga |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjeev Nair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.